T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRA
1226
DELISTED
W.R. Grace & Co.
GRA
| $14.4M | ﹤0.01% |
145,950
-10,252
| -7% | -$978K |
|
1227
Cohu
COHU
$2.76B
| $14.3M | ﹤0.01% |
1,306,347
-448,903
| -26% | -$5.08M |
|
|
FPRX
1228
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $14.2M | ﹤0.01% |
622,610
+205,000
| +49% | +$5.17M |
|
1229
Copa Holdings
CPA
$6.17B
| $14M | ﹤0.01% |
138,750
-37,410
| -21% | -$4.06M |
|
|
FCE.A
1230
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $14M | ﹤0.01% |
548,430
+190,500
| +53% | +$4.67M |
|
1231
Lincoln Electric
LECO
$15.5B
| $14M | ﹤0.01% |
213,520
-13,785
| -6% | -$934K |
|
1232
TechnipFMC
FTI
$30.1B
| $13.9M | ﹤0.01% |
506,371
+411
| +0.1% | +$12K |
|
|
TEN
1233
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $13.9M | ﹤0.01% |
242,850
+11,800
| +5% | +$653K |
|
|
SWI
1234
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $13.9M | ﹤0.01% |
272,100
+41,100
| +18% | +$2.04M |
|
|
BEL
1235
DELISTED
Belmond Ltd.
BEL
| $13.9M | ﹤0.01% |
1,134,970
-319,860
| -22% | -$3.69M |
|
1236
Huron Consulting
HURN
$2.47B
| $13.9M | ﹤0.01% |
209,384
+20,000
| +11% | +$1.4M |
|
|
SCG
1237
DELISTED
Scana
SCG
| $13.8M | ﹤0.01% |
250,889
+3,500
| +1% | +$206K |
|
|
CHK
1238
DELISTED
Chesapeake Energy Corporation
CHK
| $13.7M | ﹤0.01% |
4,827
-5,289
| -52% | -$18.7M |
|
1239
Cincinnati Financial
CINF
$26.5B
| $13.6M | ﹤0.01% |
255,419
+19,200
| +8% | +$1.01M |
|
1240
Sociedad Química y Minera de Chile
SQM
$20.6B
| $13.6M | ﹤0.01% |
763,681
+627,655
| +461% | +$14.3M |
|
1241
Allot
ALLT
$388M
| $13.6M | ﹤0.01% |
1,543,830
+11,950
| +0.8% | +$110K |
|
|
SP
1242
DELISTED
SP Plus Corporation
SP
| $13.6M | ﹤0.01% |
620,480
+83,400
| +16% | +$1.87M |
|
|
STRZA
1243
DELISTED
Starz - Series A
STRZA
| $13.5M | ﹤0.01% |
392,850
+26,434
| +7% | +$830K |
|
1244
Pultegroup
PHM
$24.9B
| $13.5M | ﹤0.01% |
606,712
+69,700
| +13% | +$1.52M |
|
1245
Hasbro
HAS
$13.6B
| $13.5M | ﹤0.01% |
212,712
-471,140
| -69% | -$27.7M |
|
1246
Perdoceo Education
PRDO
$1.99B
| $13.3M | ﹤0.01% |
+2,645,110
| New | +$15.3M |
|
1247
Targa Resources
TRGP
$57.2B
| $13.3M | ﹤0.01% |
138,600
+18,500
| +15% | +$1.73M |
|
|
ARC
1248
DELISTED
ARC Document Solutions, Inc.
ARC
| $13.3M | ﹤0.01% |
1,438,402
+13,660
| +1% | +$124K |
|
|
WBMD
1249
DELISTED
WebMD Health Corp.
WBMD
| $13.2M | ﹤0.01% |
302,170
+18,824
| +7% | +$782K |
|
|
VIRX
1250
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $13.2M | ﹤0.01% |
25,694
-1,306
| -5% | -$659K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.